Cowen & Co healthcare analysts provide updates following successful phase three trial for Exelixis, Inc.’s (NASDAQ:EXEL) drug, Cabozantinib, and Avalanche Biotechnologies Inc’s (NASDAQ:AAVL) …
Avalanche Biotechnologies Inc (“Avalanche”) (NASDAQ:AAVL) and Annapurna Therapeutics SAS (“Annapurna”), a privately held biopharmaceutical company, announced that they have entered into a definitive agreement …
Avalanche Biotechnologies Inc (NASDAQ:AAVL), a biopharmaceutical company committed to improving or preserving the sight of people suffering from serious eye diseases with an unmet …
In a research report published Friday, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL), and reduced the …
El Pollo LoCo Holdings Inc (NASDAQ:LOCO) shares plummeted more than -18% in pre-market trading down to $18.74, after the restaurant chain missed its …
Avalanche Biotechnologies Inc (NASDAQ:AAVL), a biopharmaceutical company committed to improving or preserving the sight of people suffering from blinding eye diseases with an unmet …
In a research report published Monday, Chardan analyst Gbola Amusa reiterated a Neutral rating on shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL), while reducing the price …
In a research report published Tuesday, Chardan analyst Gbola Amusa upgraded shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL) from Sell to Neutral rating, as his price …
